Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine
- PMID: 25520938
- PMCID: PMC4264973
- DOI: 10.7603/s40681-014-0025-y
Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine
Abstract
Mass spectrometry (MS) is currently the most promising tool for studying proteomics to investigate largescale proteins in a specific proteome. Emerging MS-based proteomics is widely applied to decipher complex proteome for discovering potential biomarkers. Given its growing usage in clinical medicine for biomarker discovery to predict, diagnose and confer prognosis, MS-based proteomics can benefit study of personalized medicine. In this review we introduce some fundamental MS theory and MS-based quantitative proteomic approaches as well as several representative clinical MS-based proteomics issues in Chest Medicine, Gerontology, and Nephrology.
Keywords: Chest Medicine;; Gerontology; Mass spectrometry;; Nephrology;; Personalized medicine;; Proteomics;.
Figures


References
-
- Pandey A, Mann M. Proteomics to study genes and genomes. Nature. 2000;405:837–46. - PubMed
-
- Witze ES, Old WM, Resing KA, Ahn NG. Mapping protein posttranslational modifications with mass spectrometry. Nature Methods. 2007;4:798–806. - PubMed
-
- Wu CC, MacCoss MJ, Howell KE, Yates JR. A method for the comprehensive proteomic analysis of membrane proteins. Nature Biotechnology. 2003;21:532–8. - PubMed
-
- Chen CJ, Chen WY, Tseng MC, Chen YR. Tunnel frit: a nonmetallic in-capillary frit for nanoflow ultra high-performance liquid chromatography- mass spectrometryapplications. Anal Chem. 2012;84:297–303. - PubMed
-
- Görg A, Postel W, Günther S. Two-dimensional electrophoresis. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 1988;9:531–46. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources